Cargando…

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma()

Bi-allelic inactivation of the VHL gene on chromosome 3p is the characteristic feature in most clear cell renal cell carcinomas (ccRCC). Frequent gene alterations were also identified in SETD2, BAP1 and PBRM1, all of which are situated on chromosome 3p and encode histone/chromatin regulators. The re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bihr, Svenja, Ohashi, Riuko, Moore, Ariane L., Rüschoff, Jan H., Beisel, Christian, Hermanns, Thomas, Mischo, Axel, Corrò, Claudia, Beyer, Jörg, Beerenwinkel, Niko, Moch, Holger, Schraml, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355619/ https://www.ncbi.nlm.nih.gov/pubmed/30660076 http://dx.doi.org/10.1016/j.neo.2018.12.006

Ejemplares similares

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
por: Razafinjatovo, Caroline, et al.
Publicado: (2016)

Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma
por: Moore, Ariane L., et al.
Publicado: (2021)

Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC
por: Ibragimova, Ilsiya, et al.
Publicado: (2013)

Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma
por: Piva, Francesco, et al.
Publicado: (2015)

Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expression
por: Linne, Hannah, et al.
Publicado: (2017)

Detailed simulation of cancer exome sequencing data reveals differences and common limitations of variant callers
por: Hofmann, Ariane L., et al.
Publicado: (2017)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2017)

MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients
por: Lukamowicz-Rajska, Magdalena, et al.
Publicado: (2016)

Statistical tests for intra-tumour clonal co-occurrence and exclusivity
por: Kuipers, Jack, et al.
Publicado: (2021)

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma
por: Murakami, A, et al.
Publicado: (2017)

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Aili, Abudureyimujiang, et al.
Publicado: (2021)

The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth
por: Lobo, João, et al.
Publicado: (2021)

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
por: Carril-Ajuria, Lucía, et al.
Publicado: (2019)

Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients
por: Ohashi, Riuko, et al.
Publicado: (2020)

Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma
por: Ohashi, Riuko, et al.
Publicado: (2019)

PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
por: Chowdhury, Basudev, et al.
Publicado: (2016)

IL‐8 and CXCR1 expression is associated with cancer stem cell‐like properties of clear cell renal cancer
por: Corrò, Claudia, et al.
Publicado: (2019)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

Read length versus Depth of Coverage for Viral Quasispecies Reconstruction
por: Zagordi, Osvaldo, et al.
Publicado: (2012)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

Genomic Profiling of Malignant Peritoneal Mesothelioma Reveals Recurrent Alterations in Epigenetic Regulatory Genes BAP1, SETD2, and DDX3X
por: Joseph, Nancy M., et al.
Publicado: (2016)

PBRM1 Regulates Stress Response in Epithelial Cells
por: Porter, Elizabeth G., et al.
Publicado: (2019)

Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway
por: Gad, Sophie, et al.
Publicado: (2021)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023)

PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma
por: Saiga, Kazuho, et al.
Publicado: (2022)

Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis
por: Demirel, Emin, et al.
Publicado: (2023)

PBRM1 bromodomains associate with RNA to facilitate chromatin association
por: De Silva, Saumya M, et al.
Publicado: (2023)

Quantifying cancer progression with conjunctive Bayesian networks
por: Gerstung, Moritz, et al.
Publicado: (2009)

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
por: Dannenmann, Stefanie Regine, et al.
Publicado: (2013)

An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
por: Wang, Yuanyuan, et al.
Publicado: (2016)

Comments on “Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis”
por: Pontes-Silva, André, et al.
Publicado: (2023)

A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
por: Ge, Yu-Zheng, et al.
Publicado: (2017)

Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development
por: Polanetzki, Vanessa, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors
por: Liu, Jin, et al.
Publicado: (2022)

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers
por: Dai, Jiali, et al.
Publicado: (2023)

A switch in transcription and cell fate governs the onset of an epigenetically-deregulated tumor in Drosophila
por: Torres, Joana, et al.
Publicado: (2018)

Erratum to: An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
por: Wang, Yuanyuan, et al.
Publicado: (2016)

PBRM1 deficiency oncogenic addiction is associated with activated AKT–mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells
por: Tang, Yu, et al.
Publicado: (2022)

RhierBAPS: An R implementation of the population clustering algorithm hierBAPS
por: Tonkin-Hill, Gerry, et al.
Publicado: (2018)

Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma
por: Velagapudi, Srividya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m330jlp34bo55ap14gqf56qjsq